Who invested in Arcutis Biotherapeutics

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$245Mraised across 2 rounds since 2019, from 2 sources

$95MSeries C$150MRound

Latest round: Round, $150MFeb 2024
Step-upi: 1.6×
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20202021202220232024

$95MSeries C$150MRound

First round: Series C, $95M
Biggest round: $150M
Between rounds: 4.3 years

The rounds

Feb 2024
Round$150M1 new3 returning
Source recorded
Oct 2019
Series C$95M5 new
- Goldman Sachs
- BlackRock
- Vivo Capital
- Omega Funds
- Pivotal BioVentures
Reported by SfvbjSEC filing: $94M sold, first sale Oct 2019

Founders and team

From Arcutis Biotherapeutics's own website and the SEC filings it signed: 12 on the team.

Aleen HosdaghianVice President, Marketing
Charlotte MerrittVice President, Regulatory Affairs
Chris KlocVice President, Dermatology Sales
Meg EliasVice President, Clinical Operations
Mike InjaychockVice President, Commercial Operations
Frank WatanabePresident and CEO
Bethany DudekChief Technical Officer
Latha VairavanChief Financial Officer
Raj MadanChief Digital and Information Technology Officer
Robert LisickiChief Commercial Officer
Todd TuckerChief Human Resources Officer
Todd Franklin WatanabeExecutive Officer, Directori

On the board, as filediAlexander Franklin AsamBhaskar Franklin ChaudhuriDaniel Franklin EstesJonathan Franklin SilversteinPatrick Franklin HeronRicky Franklin Sun

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2019Round2024

Goldman Sachs

BlackRock

Vivo Capital

RA Capital Management

Omega FundsPivotal BioVentures

Everyone who backed them

Goldman SachsPrivate equity2rounds

BlackRockAsset manager2rounds

Vivo CapitalPrivate equity2rounds

RA Capital ManagementPrivate equity1round

Omega FundsVC firm1round

Pivotal BioVenturesno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Arcutis Biotherapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.